author-photo

François-Clément Bidard

Curie Institute
PSL Research University
Versailles Saint-Quentin-en-Yvelines University

244

Papers

7126

Citations

Citation Trend

Filter By

Papers (244) Sort By

Journal Conference Others

Abstract CT189: Characterization of ESR1 mutations at metastatic relapse and outcome under first line aromatase inhibitor and palbociclib in the PADA-1 trial

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Does sacituzumab-govitecan act as a conventional antibody drug conjugate (ADC), a prodrug of SN-38 or both?

2021 Annals of Translational Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer.

2021
Show All
- Source
- Cite
- Save
Citations (2)
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.

2021 Genome Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD1-05: Latest findings from the breast cancer cohort in SUMMIT - a phase 2 ‘basket’ trial of neratinib + trastuzumab + fulvestrant forHER2-mutant, hormone receptor-positive, metastatic breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.

2021 Breast Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Alpelisib and fulvestrant efficacy in HR-positive HER2-negative PIK3CA-mutant advanced breast cancer: Data from the French early access program.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Enhancer rewiring in tumors: an opportunity for therapeutic intervention.

2021 Oncogene
Show All
- Source
- Cite
- Save
Citations (3)
Abstract PS10-40: Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of AI and palbociclib in ER+ HER2- advanced breast cancer patients relapsing during adjuvant tamoxifen: An exploratory analysis of the PADA-1 trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)